| An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage AM Newman, SV Bratman, J To, JF Wynne, NCW Eclov, LA Modlin, ... Nature medicine 20 (5), 548-554, 2014 | 2352 | 2014 |
| Lung cancer screening, version 3.2018, NCCN clinical practice guidelines in oncology DE Wood, EA Kazerooni, SL Baum, GA Eapen, DS Ettinger, L Hou, ... Journal of the National Comprehensive Cancer Network 16 (4), 412-441, 2018 | 623 | 2018 |
| Small cell lung cancer GP Kalemkerian, W Akerley, P Bogner, H Borghaei, LQM Chow, ... Journal of the National Comprehensive Cancer Network 11 (1), 78-98, 2013 | 495 | 2013 |
| Small cell lung cancer, version 2.2022, NCCN clinical practice guidelines in oncology AKP Ganti, BW Loo, M Bassetti, C Blakely, A Chiang, TA D'Amico, ... Journal of the National Comprehensive Cancer Network 19 (12), 1441-1464, 2021 | 295 | 2021 |
| NCCN guidelines insights: small cell lung cancer, version 2.2018 GP Kalemkerian, BW Loo, W Akerley, A Attia, M Bassetti, Y Boumber, ... Journal of the National Comprehensive Cancer Network 16 (10), 1171-1182, 2018 | 276 | 2018 |
| Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3). DJ Kwiatkowski, VW Rusch, JE Chaft, BE Johnson, A Nicholas, II Wistuba, ... Journal of Clinical Oncology 37 (15_suppl), 8503-8503, 2019 | 195 | 2019 |
| Lymph node evaluation achieved by open lobectomy compared with thoracoscopic lobectomy for N0 lung cancer RE Merritt, CD Hoang, JB Shrager The Annals of thoracic surgery 96 (4), 1171-1177, 2013 | 139 | 2013 |
| Costs of diagnostic assessment for lung cancer: a medicare claims analysis T Lokhandwala, MA Bittoni, RA Dann, AO D'Souza, M Johnson, RJ Nagy, ... Clinical lung cancer 18 (1), e27-e34, 2017 | 114 | 2017 |
| NCCN guidelines® insights: lung cancer screening, version 1.2022: featured updates to the NCCN guidelines DE Wood, EA Kazerooni, D Aberle, A Berman, LM Brown, GA Eapen, ... Journal of the National Comprehensive Cancer Network 20 (7), 754-764, 2022 | 113 | 2022 |
| Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non–small cell lung cancer PJ Kneuertz, DH Cheufou, DM D'Souza, K Mardanzai, M Abdel-Rasoul, ... The Journal of Thoracic and Cardiovascular Surgery 158 (5), 1457-1466. e2, 2019 | 109 | 2019 |
| Hospital cost and clinical effectiveness of robotic-assisted versus video-assisted thoracoscopic and open lobectomy: a propensity score–weighted comparison PJ Kneuertz, E Singer, DM D'Souza, M Abdel-Rasoul, SD Moffatt-Bruce, ... The Journal of thoracic and cardiovascular surgery 157 (5), 2018-2026. e2, 2019 | 108 | 2019 |
| Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses S Worgall, A Busch, M Rivara, D Bonnyay, PL Leopold, R Merritt, ... Journal of virology 78 (5), 2572-2580, 2004 | 103 | 2004 |
| Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation RE Merritt, RI Whyte, NT D'Arcy, CD Hoang, JB Shrager The Annals of thoracic surgery 92 (6), 2034-2040, 2011 | 98 | 2011 |
| Computed tomography-assessed skeletal muscle mass as a predictor of outcomes in lung cancer surgery JM Nishimura, AZ Ansari, DM D’Souza, SD Moffatt-Bruce, RE Merritt, ... The Annals of thoracic surgery 108 (5), 1555-1564, 2019 | 88 | 2019 |
| A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease B Gu, BM Burt, RE Merritt, S Stephanie, V Nair, CD Hoang, JB Shrager The Annals of thoracic surgery 96 (2), 411-418, 2013 | 88 | 2013 |
| Long-term oncologic outcomes after robotic lobectomy for early-stage non–small-cell lung cancer versus video-assisted thoracoscopic and open thoracotomy approach PJ Kneuertz, DM D’Souza, M Richardson, M Abdel-Rasoul, ... Clinical lung cancer 21 (3), 214-224. e2, 2020 | 82 | 2020 |
| PS01. 05 surgical and clinical outcomes with neoadjuvant atezolizumab in resectable stage IB–IIIB NSCLC: LCMC3 trial primary analysis J Lee, J Chaft, A Nicholas, A Patterson, S Waqar, E Toloza, E Haura, ... Journal of Thoracic Oncology 16 (3), S59-S61, 2021 | 80 | 2021 |
| In vivo gene transfer of pigment epithelium-derived factor inhibits tumor growth in syngeneic murine models of thoracic malignancies A Mahtabifard, RE Merritt, RE Yamada, RG Crystal, RJ Korst The Journal of thoracic and cardiovascular surgery 126 (1), 28-38, 2003 | 70 | 2003 |
| Cancer of the lung: Non–small cell lung cancer and small cell lung cancer LH Araujo, L Horn, RE Merritt, K Shilo, M Xu-Welliver, DP Carbone Abeloff's clinical oncology, 1108-1158. e16, 2020 | 63 | 2020 |
| miR-1 induces growth arrest and apoptosis in malignant mesothelioma Y Xu, M Zheng, RE Merritt, JB Shrager, HA Wakelee, RA Kratzke, ... Chest 144 (5), 1632-1643, 2013 | 63 | 2013 |
